About   Help   FAQ
Phenotypes associated with this allele
Allele Symbol
Allele Name
Allele ID
Tg(Cryaa-TAg,Ins2-CALM1)26Ove
transgene insertion 26, Paul Overbeek
MGI:3576672
Summary 3 genotypes


Genotype
MGI:4360116
cx1
Allelic
Composition
Tg(Cryaa-TAg,Ins2-CALM1)26Ove/0
Tg(Myh6-SOD2,Tyr)3Pne/0
Genetic
Background
FVB-Tg(Cryaa-TAg,Ins2-CALM1)26Ove Tg(Myh6-SOD2,Tyr)3Pne
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Tg(Cryaa-TAg,Ins2-CALM1)26Ove mutation (1 available)
Tg(Myh6-SOD2,Tyr)3Pne mutation (1 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
cellular
N
• no diabetes-induced increases in mitochondrial area, number, protein, or DNA content are observed

homeostasis/metabolism
• nonfaster hyperglycemia usually exceeds >600 mg/dl

cardiovascular system
N
• no damage is seen in the heart in contrast to single transgenic Tg(Ins2-CALM1)26Ove mice
• contractile parameters are normalized in double transgenic hearts




Genotype
MGI:3576767
tg2
Allelic
Composition
Tg(Cryaa-TAg,Ins2-CALM1)26Ove/0
Genetic
Background
FVB(Cg)-Tg(Cryaa-Tag,Ins2-CALM1)26Ove/PneJ
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Tg(Cryaa-TAg,Ins2-CALM1)26Ove mutation (1 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
homeostasis/metabolism
• reduced pancreatic insulin levels; early onset and increased severity with age
• pancreatic insulin content was 28% of control levels
• insulin mRNA levels were also reduced
• elevated serum glucagon levels
• markedly lower serum insulin levels

renal/urinary system

endocrine/exocrine glands
• the number of beta cells per islet was reduced
• reduced pancreatic insulin levels; early onset and increased severity with age
• pancreatic insulin content was 28% of control levels
• insulin mRNA levels were also reduced

Mouse Models of Human Disease
DO ID OMIM ID(s) Ref(s)
type 1 diabetes mellitus DOID:9744 OMIM:222100
J:97926




Genotype
MGI:4360179
tg3
Allelic
Composition
Tg(Cryaa-TAg,Ins2-CALM1)26Ove/0
Genetic
Background
FVB-Tg(Cryaa-TAg,Ins2-CALM1)26Ove
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Tg(Cryaa-TAg,Ins2-CALM1)26Ove mutation (1 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
cellular
• swollen mitochondria and broken mitochondrial double membranes are observed
• hearts have increased mitochondrial mass, as well as greater area and number
• respiratory control ratio (RCR) and state 3 respiration are significantly impaired in mitochondria

cardiovascular system
• hearts have many focal areas of damage with swollen mitochondria, mottled matrix and broken mitochondrial double membranes
• progressive increase in renal vascular resistance beginning at 3 months of age
• diastolic blood pressure is elevated in conscious mutants at 3 months of age when measured using a tail-cuff monitor
• by 8 months of age, both diastolic and systolic blood pressure is increased in conscious mutants
• under anesthesia, when measured by intravascular connulation, mutants exhibit a similar blood pressure to anesthetized controls, however this is reduced compared to conscious mutants

homeostasis/metabolism
• blood glucose levels are more than 2-fold higher than normal by 20 days after birth and continue to rise until at least 60 days of age (J:94602)
• some mutants develop hypoalbuminemia due to excessive loss of albumin
• albumin excretion rate increases progressively with age and exceeds 15,000 ug/24 hr at 9 months of age

adipose tissue
• loss of fat tissue by 5 months of age

growth/size/body
N
• mutants exhibit normal weight gain and body weight
• loss of fat tissue by 5 months of age
• 2-fold increase in kidney weight between 2 and 5 months of age

liver/biliary system

renal/urinary system
• progressive increase in renal vascular resistance beginning at 3 months of age
• albumin excretion rate increases progressively with age and exceeds 15,000 ug/24 hr at 9 months of age
• kidney shows dilation of the ducts, atrophy of tubular cells, protein casts in the duct lumen, and prominent infiltration of mononuclear cells
• 2-fold increase in kidney weight between 2 and 5 months of age
• glomeruli exhibit a thickened and irregular basement membrane
• expanded mesangium showing enlarged mesangial fraction and mesangial volume, with the greatest rate increase during 2.5-6 months of age
• diffuse and nodular expansion of mesangial matrix in mutants over 2 months of age
• diffuse and nodular glomerulosclerotic lesions
• nodules are acellular and are similar to Kimmelsteil-Wilson lesions in size
• glomerular volume is enlarged, with the greatest rate increase during 2.5-6 months of age
• seen in many mutants over 5 months of age
• expansion of kidney tubules; average cortical tubule cross-sectional area (minus the lumen) is 34% greater in 9 month old mutants than controls
• significant fibrosis in the kidney by 5 months of age
• tubulointerstitial fibrosis
• many mutants over 5 months of age exhibit bladder stasis
• distended bladders are seen in many mutants over 5 months of age
• glomerular filtration rate increases significantly from 2 to 3 months of age but then decreases significantly from 5 to 9 months of age
• decline in glomerular filtration rate coincides with an increase in renal vascular resistance
• by 2 months of age

Mouse Models of Human Disease
DO ID OMIM ID(s) Ref(s)
type 1 diabetes mellitus DOID:9744 OMIM:222100
J:94602





Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
04/09/2024
MGI 6.23
The Jackson Laboratory